Research uncovers molecule's role in inhibiting organ rejection

06/23/2008 | Forbes

Scientists found that an immune molecule known as HLA-G dimer can help prevent organ- and tissue-transplant rejection in patients by binding to its inhibitory receptor ILT4 to activate a signaling pathway in which immune molecules IL-6 and STAT3 play a role. They believe that boosting the molecule's mechanism can curb immune activity in patients with autoimmune disorders and organ transplants.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL